S10 Ep16: Mims Expands on the Evaluation of Emavusertib in the TakeAim Leukemia Trial of AML and MDS

from OncLive® On Air · host OncLive® On Air

Dr Mims discusses the utility of emavusertib in acute myeloid leukemia and myelodysplastic syndrome and the rationale for the TakeAim Leukemia trial.

Episode metadata supplied by the publisher feed · Published Feb 26, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

S10 Ep16: Mims Expands on the Evaluation of Emavusertib in the TakeAim Leukemia Trial of AML and MDS

0:00 10:05

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 10 minutes long.

This episode was published on February 26, 2024.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!